查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1263898

In Situ雜合反應的全球市場:趨勢，機會，競爭分析(2023年～2028年)

In Situ Hybridization Market: Trends, Opportunities and Competitive Analysis [2023-2028]
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

全球In Situ雜合反應的市場規模，預計至2028年達到24億美元，2023年～2028年以9.4％的年複合成長率成長。市場主要促進因素，是遺傳性疾病的流行，及癌症治療的認識提高，政府的配合措施的活躍。

本報告提供全球In Situ雜合反應市場相關調查分析，趨勢與預測，成長機會分析，企業簡介等資訊。

目錄

第1章 摘要整理

第2章 全球In Situ雜合反應市場:市場動態

  • 簡介，背景，分類
  • 供應鏈
  • 產業的推動因素與課題

第3章 市場趨勢與預測分析(2017年～2028年)

  • 宏觀經濟趨勢(2017年～2022年)與預測(2023年～2028年)
  • 全球In Situ雜合反應市場趨勢(2017年～2022年)與預測(2023年～2028年)
  • 全球In Situ雜合反應市場:各技術
    • 螢光In Situ雜合反應(FISH)
    • 顯像In Situ雜合反應(CISH)
  • 全球In Situ雜合反應市場:各探針
    • DNA
    • RNA
  • 全球In Situ雜合反應市場:各產品
    • 器具
    • 套件，探針
    • 軟體
    • 服務
  • 全球In Situ雜合反應市場:各用途
    • 癌症
    • 細胞遺傳學
    • 發生生物學
    • 感染疾病
    • 其他
  • 全球In Situ雜合反應市場:各最終用途產業
    • 研究，診斷研究所
    • CRO
    • 學術機構
    • 其他

第4章 市場趨勢與預測分析:各地區(2017年～2028年)

  • 全球In Situ雜合反應市場:各地區
  • 北美的In Situ雜合反應市場
    • 北美的In Situ雜合反應市場:各技術
    • 北美的In Situ雜合反應市場:各最終用途產業
  • 歐洲的In Situ雜合反應市場
    • 歐洲的In Situ雜合反應市場:各技術
    • 歐洲的In Situ雜合反應市場:各最終用途產業
  • 亞太地區的In Situ雜合反應市場
    • 亞太地區的In Situ雜合反應市場:各技術
    • 亞太地區的In Situ雜合反應市場:各最終用途產業
  • 其他地區的In Situ雜合反應市場
    • 其他地區的In Situ雜合反應市場:各技術
    • 其他地區的In Situ雜合反應市場:各最終用途產業

第5章 競爭的分析

  • 產品系列分析
  • 經營的整合
  • 波特的五力分析

第6章 成長機會及策略的分析

  • 成長機會分析
    • 全球In Situ雜合反應市場成長機會:各技術
    • 全球In Situ雜合反應市場成長機會:各探針
    • 全球In Situ雜合反應市場成長機會:各產品
    • 全球In Situ雜合反應市場成長機會:各用途
    • 全球In Situ雜合反應市場成長機會:各最終用途
    • 全球In Situ雜合反應市場成長機會:各地區
  • 全球In Situ雜合反應市場上新的趨勢
  • 策略的分析
    • 新產品的開發
    • 全球In Situ雜合反應市場生產能力擴大
    • 全球In Situ雜合反應市場的合併，收購，合資企業
    • 檢定和授權

第7章 主要企業的企業簡介

  • Thermo Fisher Scientific
  • Abbott
  • PerkinElmer
  • BioView
  • Agilent Technologies
簡介目錄

In Situ Hybridization Market Trends and Forecast

The future of the in situ hybridization market looks promising with opportunities in the research & diagnostic laboratory, CRO, and academic institute end use industries. The global in situ hybridization market is expected to reach an estimated $2.4 billion by 2028 with a CAGR of 9.4% from 2023 to 2028. The major drivers for this market are increasing prevalence of genetic diseases, rising awareness towards cancer therapeutics, and growing government initiatives.

In Situ Hybridization Market by Technology, Probe, Product, Application, End Use Industry, and Region

A more than 150-page report is developed to help in your business decisions. A sample figure with some insights is shown below.

In Situ Hybridization Market by Segments

In Situ Hybridization Market by Segment

The study includes trends and forecast for the global in situ hybridization market by technology, probe, product, application, end use industry, and region, as follows:

In Situ Hybridization Market by Technology [Value ($B) Shipment Analysis from 2017 to 2028]:

Fluorescent In Situ Hybridization (FISH)

Chromogenic In Situ Hybridization (CISH)

In Situ Hybridization Market by Probe [Value ($B) Shipment Analysis from 2017 to 2028]:

DNA

RNA

In Situ Hybridization Market by Product [Value ($B) Shipment Analysis from 2017 to 2028]:

Instruments

Kits & Probes

Software

Services

In Situ Hybridization Market by Application [Value ($B) Shipment Analysis from 2017 to 2028]:

Cancer

Cytogenetics

Developmental Biology

Infectious Diseases

Others

In Situ Hybridization Market by End Use Industry [Value ($B) Shipment Analysis from 2017 to 2028]:

Research & Diagnostic Laboratories

CROs

Academic Institutes

Others

In Situ Hybridization Market by Region [Value ($B) Shipment Analysis from 2017 to 2028]:

North America

Europe

Asia Pacific

The Rest of the World

List of In Situ Hybridization Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, in-situ hybridization companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the in-situ hybridization companies profiled in this report include-

Thermo Fisher Scientific

Abbott

PerkinElmer

BioView

Agilent Technologies

In Situ Hybridization Market Insights

Lucintel forecasts that FISH will remain the larger technology segment over the forecast period because it provides researchers with a method to visualize and map the genetic components in a single cell.

Research & diagnostic laboratories are expected to remain the largest segment due to the rising requirement for rapid & accurate diagnostic techniques.

North America will remain the largest region due to availability of technologically upgraded infrastructure, increasing prevalence of infectious diseases, and growing demand for early diagnosis of diseases in the region.

Features of the In Situ Hybridization Market

Market Size Estimates: In situ hybridization market size estimation in terms of value ($B)

Trend And Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.

Segmentation Analysis: In situ hybridization market size by various segments, such as technology, probe, product, application, end use industry, and region

Regional Analysis: In situ hybridization market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.

Growth Opportunities: Analysis on growth opportunities in different technology, probes, products, applications, end use industries, and regions for the in situ hybridization market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape for the in situ hybridization market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the in situ hybridization market size?

Answer: The global in situ hybridization market is expected to reach an estimated $2.4 billion by 2028.

Q2. What is the growth forecast for in situ hybridization market?

Answer: The global in situ hybridization market is expected to grow with a CAGR of 9.4% from 2023 to 2028.

Q3. What are the major drivers influencing the growth of the in situ hybridization market?

Answer: The major drivers for this market are increasing prevalence of genetic diseases, rising awareness towards cancer therapeutics, and growing government initiatives.

Q4. What are the major segments for in situ hybridization market?

Answer: The future of the in situ hybridization market looks promising with opportunities in the research & diagnostic laboratory, CRO, and academic institute end use industry.

Q5. Who are the key in situ hybridization companies?

Answer: Some of the key in situ hybridization companies are as follows:

Thermo Fisher Scientific

Abbott

PerkinElmer

BioView

Agilent Technologies

Q6. Which in situ hybridization segment will be the largest in future?

Answer: Lucintel forecasts that FISH will remain the larger technology segment over the forecast period because it provides researchers with a method to visualise and map the genetic components in a single cell.

Q7. In in situ hybridization market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to availability of technologically upgraded infrastructure, increasing prevalence of infectious diseases, and growing demand for early diagnosis of diseases in the region.

Q8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions

  • Q.1. What are some of the most promising, high-growth opportunities for the in situ hybridization market by technology (fluorescent in situ hybridization (FISH) and chromogenic in situ hybridization (CISH)), probe (DNA and RNA), product (instruments, kits & probes, software, and services), application (cancer, cytogenetics, developmental biology, infectious diseases, and others), end use industry (research & diagnostic laboratories, CROs, academic institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last five years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global In Situ Hybridization Market: Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2017 to 2028

  • 3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
  • 3.2: Global In Situ Hybridization Market Trends (2017-2022) and Forecast (2023-2028)
  • 3.3: Global In Situ Hybridization Market by Technology
    • 3.3.1: Fluorescent In Situ Hybridization (FISH)
    • 3.3.2: Chromogenic In Situ Hybridization (CISH)
  • 3.4: Global In Situ Hybridization Market by Probe
    • 3.4.1: DNA
    • 3.4.2: RNA
  • 3.5: Global In Situ Hybridization Market by Product
    • 3.5.1: Instruments
    • 3.5.2: Kits & Probes
    • 3.5.3: Software
    • 3.5.4: Services
  • 3.6: Global In Situ Hybridization Market by Application
    • 3.6.1: Cancer
    • 3.6.2: Cytogenetics
    • 3.6.3: Developmental Biology
    • 3.6.4: Infectious Diseases
    • 3.6.5: Others
  • 3.7: Global In Situ Hybridization Market by End Use Industry
    • 3.7.1: Research & Diagnostic Laboratories
    • 3.7.2: CROs
    • 3.7.3: Academic Institutes
    • 3.7.4: Others

4. Market Trends and Forecast Analysis by Region from 2017 to 2028

  • 4.1: Global In Situ Hybridization Market by Region
  • 4.2: North American In Situ Hybridization Market
    • 4.2.1: North American In Situ Hybridization Market by Technology: Fluorescent In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
    • 4.2.2: North American In Situ Hybridization Market by End Use Industry: Research & Diagnostic Laboratories, CROs, Academic Institutes, and Others
  • 4.3: European In Situ Hybridization Market
    • 4.3.1: European In Situ Hybridization Market by Technology: Fluorescent In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
    • 4.3.2: European In Situ Hybridization Market by End Use Industry: Research & Diagnostic Laboratories, CROs, Academic Institutes, and Others
  • 4.4: APAC In Situ Hybridization Market
    • 4.4.1: APAC In Situ Hybridization Market by Technology: Fluorescent In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
    • 4.4.2: APAC In Situ Hybridization Market by End Use Industry: Research & Diagnostic Laboratories, CROs, Academic Institutes, and Others
  • 4.5: ROW In Situ Hybridization Market
    • 4.5.1: ROW In Situ Hybridization Market by Technology: Fluorescent In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
    • 4.5.2: ROW In Situ Hybridization Market by End Use Industry: Research & Diagnostic Laboratories, CROs, Academic Institutes, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the In Global Situ Hybridization Market by Technology
    • 6.1.2: Growth Opportunities for the In Global Situ Hybridization Market by Probe
    • 6.1.3: Growth Opportunities for the In Global Situ Hybridization Market by Product
    • 6.1.4: Growth Opportunities for the In Global Situ Hybridization Market by Application
    • 6.1.5: Growth Opportunities for the In Global Situ Hybridization Market End Use Industry
    • 6.1.6: Growth Opportunities for the In Global Situ Hybridization Market by Region
  • 6.2: Emerging Trends in the Global In Situ Hybridization Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global In Situ Hybridization Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global In Situ Hybridization Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermo Fisher Scientific
  • 7.2: Abbott
  • 7.3: PerkinElmer
  • 7.4: BioView
  • 7.5: Agilent Technologies